AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2009
Dec 3, 2009
31801_dirs_2009-12-03_2bb26bd8-ab8f-45af-ae36-cfffb79d52a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2009-12-02
Reporting Person: SCHALLER CHARLES R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-12-02 | Common Stock | P | 2400 | $4.68 | Acquired | 2400 | Direct |
| 2009-12-02 | Common Stock | P | 4600 | $4.69 | Acquired | 4600 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Mar 26